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Attitudes of physicians, nurses and pharmacists  
concerning the development of clinical pharmacy
activities in a university hospital
It is essential to identify the expectations of physicians and 
nurses regarding clinical pharmacy (CP) services before its 
introduction in a hospital, because it is known that their 
expectations can substantially differ from the pharmacists’ 
point of view. Agreement of leading physicians, nurses and 
clinical pharmacists about the importance of CP activities 
in the hospital was evaluated using five point Likert scale 
questionnaire. Two groups of CP activities were set; the ac-
tivities related to the hospital system (first group) and the 
activities connected with an individual patient (second 
group). Total mean score of agreement of physicians with 
the first and second group of CP activities is 4.28 and 3.73, 
respectively, while these scores are lower for nurses (3.87 
and 3.38 for the first and second group, respectively). Phar-
macists’ total mean scores are highest, 4.57 and 4.23 for the 
first and second group, respectively.
Keywords: clinical pharmacist, activities, physicians, nurses
In contrast to traditional pharmacy as a profession, with medicine being its point of 
interest, the point of interest of clinical pharmacy is the patient (1). Clinical pharmacy 
service is a set of activities including, but not limited to, provision and evaluation of all 
kinds of information regarding medicines, cooperation in planning and conducting phar-
macotherapy, medication reconciliation, verification of prescribing, preparation for medi-
cine administration, outcomes assessment, pharmacovigilance issues, and safe and cost 
effective medicine utilization assurance (2, 3).
Acceptance of a clinical pharmacist by other members of the health care team depends 
mainly on their individual attitude, perception and personal experience (4). The physi-
cians’ fear of losing independence and professional autonomy is one of the barriers and 
reasons for the negative attitude towards clinical pharmacists, perceived as inspectors of 
their work (5, 6). On the other side, there is a growing number of literature data about the 
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A plethora of research work has been done in order to evaluate the clinical pharmacy 
services after their introduction (2, 3, 5, 6, 8–17). In contrast, studies exploring the stake-
holders’ needs, expectations, and perceptions of clinical pharmacy services before their 
introduction are very rare. Only a few studies investigated the perception of clinical phar-
macy services by all three professional groups – pharmacists, physicians and nurses (9, 15, 
16). Dussart et al. (15) investigated satisfaction with only one particular pharmacist’s ser-
vice, i.e., individualized dispensing system. Gillespie et al. (11) conducted three different 
surveys, each designed for one profession only. Compared to the existing research, the 
added value of our research is that the survey was conducted before the clinical pharmacy 
service was introduced, it included the vast majority of all clinical pharmacy activities and 
the same questionnarie was used for all three professional groups.
The purpose of our research was to evaluate the positions of the leading physicians 
and head nurses on clinical pharmacy activities before their introduction in the hospital 
based on a comprehensive questionnaire containing all known clinical pharmacists’ activi-
ties. Moreover, potential differences in perception and expectations from the clinical phar-
macy service among pharmacists, physicians, and nurses were evaluated.
ExPERIMENTAL
Clinical environment description
The study was conducted at the University Medical Centre (UMC) Ljubljana, Slovenia. 
The medical centre has 2200 beds and over 100,000 hospitalizations, more than 750,000 
ambulatory visits and over 250,000 functional diagnostic visits annually. There are 64 clin-
ics, clinical departments, centres and institutes operating within the hospital. Forty-nine of 
them use medical preparations while performing their practice. Six out of 49 departments 
have negligible drug consumption, while a considerable amount of medications is used in 
the other 43 departments. We can therefore suppose that clinical pharmacy service would 
being valuable there. Hospital pharmacy supplies medications, including different galenic, 
magistral and parenteral preparations to clinical departments. At the time of conducting 
the survey there were 27 employed pharmacists, all working in the pharmacy. There was 
no clinical pharmacy service in hospital wards.
Questionnaire (perception assessment tool) generation
An internet search in Medline and PubMed and in the Firefox browser was performed 
for the keywords: clinical pharmacy, physician’s attitude to pharmacist, clinical pharmacy 
activities, clinical pharmacy services, physician-pharmacist collaboration, physicians’ ac-
ceptance of pharmacist, clinical pharmacy, health care services research, services develop-
ment, consumers’ attitude, consumers’ perception, consumers’ satisfaction, consumers’ 
expectations. Primary and secondary sources were selected, including web pages of profes-
sional pharmaceutical organizations and other relevant data about clinical pharmacy serv-
ices. These sources were used to make a list of clinical pharmacy activities, which was fur-
ther used to construct a survey questionnaire.
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Questionnaire structure
A questionnaire with the Likert measurement scale was constructed to conduct a de-
scriptive observational study on the perception of physicians, nurses and pharmacists 
about the importance of each of the listed activities of clinical pharmacists. Questions/state-
ments in the first part of the questionnaire (questions 1–17) pertain to the clinical pharmacy 
activities in the hospital system, while the second part of the questionnaire (questions 18–
36) contains activities directly connected with individual patient care. The participants had 
to choose the level of agreement on the Likert scale from 1 (I totally disagree) to 5 (I totally 
agree) with each of the listed affirmative statements in the questionnaire.
Questionnaire validation
The questionnaire was first tested on a group of pharmacists to check the scope of se-
lected clinical pharmacy activities. In the second step, it was validated by a group of experts: 
a physician, a non-hospital pharmacist and an independent human resource manager.
Study participants
The questionnaire was sent by e-mail to all 27 pharmacists employed in the hospital 
pharmacy at the time of survey. They were asked to fill in the questionnaire only in case 
they wanted to practice clinical pharmacy in the future. In addition, the questionnaire was 
sent to 43 physicians – medical directors or heads of departments – and to their head nurs-
es. We decided to perform this study on the basis of directed sampling, because we were 
interested in getting the middle management’s opinion before introducting the new serv-
ice. Conducting the survey among the leading hospital staff served as a kind of promo-
tional activity for the new clinical pharmacy service. Study participants were instructed 
that they could freely distribute the survey to other leading physicians in the ward accord-
ing to their own judgement. The participants could choose to fill in the questionnaire elec-
tronically or to print it out and fill it in manually.
The survey results were collected in an MS Excel database, together with the demo-
graphic data of each respondent: profession (physician, nurse or pharmacist), name of the 
clinic/clinical department, age and gender, and the level of agreement (from 1 to 5) with 
each statement about the clinical pharmacy activities.
Statistical analysis
Questionnaire data were presented as mean scores of agreement for each statement, 
for each profession separately. The differences between pharmacists, physicians, and nurs-
es in the mean score of each item (statement agreement) were analysed using the Kruskal-
Wallis non parametric ANOVA test. For pairwise comparisons between professional 
groups, non parametric Mann-Whitney U test was applied with Holm’s correction method 
for control of type I error.
Additionally, total mean score for each profession was calculated as the mean value of 
mean scores of all statements obtained for each participant. This was calculated separately 
for the first (statements regarding clinical pharmacy activities in the hospital system) and 
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the second part of the questionnaire (statements regarding activities directed at the pa-
tient). In case of missing data for a statement score of a specific participant, the total mean 
score was still calculated on the basis of the data obtained from other statement scores of 
this specific participant). The differences between pharmacists, physicians and nurses in 
the total mean score of agreement with each statement were analysed with a one way 
ANOVA test. Homogeneity of variances was assessed with Levene’s test. In cases of hete-
rogeneity of variances, we assessed the differences in perception between professional 
groups using Welch’s test. For pairwise comparisons between professional groups, post hoc 
tests (Scheffe’s test in cases of homogeneous variances and Games-Howell’s test in cases of 
heterogoneous variances) were used. Statistical analysis was performed in the IBM SPSS 
Statistics programme, version 21 (IBM Corporation, Armonk, New York, USA). Signifi-
cance level was set at 0.05.
RESULTS AND DISCUSSION
In total 40 physicians (46 % women mean age 45 years, and 54 % men mean age 51 
years) have filled the questionnaire. In the nursing group, all of 42 participating nurses 
were women, mean age was 46 years. Out of total 27 pharmacists, 13 (85 % women, mean 
age of women and men was 45 years and 30 years, respectively) expressed their wish to 
work as clinical pharmacists and filled in the questionnaire. All together, 82 responses from 
physicians and nurses as users of the clinical pharmacy service were analysed in compari-
son with 13 responses of pharmacists as potential providers of the service.
The aggregated score of agreement with all the statements about the role of a clinical 
pharmacist in the hospital system and his/her role in the patient-connected activities for 
each professional group, i.e., pharmacists, physicians and nurses, are shown in Fig. 1. There 
Fig. 1. Total mean score of agreement (Likert scale) with all statements about the role of a clinical 
pharmacist in the hospital system, for pharmacists (n = 13), physicians (n = 40) and nurses (n = 42). 
Error bars represent 95 % confidence interval of the mean value. Asterisks denote statistically sig-
nificant pairwise comparisons among professions, obtained separately for items appraising the roles 
for the hospital system (circles, 17 items) and for the patient (triangles, 19 items).
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are significant differences in the total mean score of agreement about the role of clinical 
pharmacists in the hospital system between pharmacists and nurses, whereas the differ-
ences between pharmacists and physicians, and between physicians and nurses were not 
statistically significant. Differences in the total mean score of agreement about the role of 
clinical pharmacist for the patient were statistically significant when comparing pharma-
cists with physicians and nurses, whereas the differences between physicians and nurses 
were not statistically significant.
The role of a clinical pharmacist in the hospital system
The mean score of agreement with all statements about the role of clinical pharmacists 
in the hospital system aggregated for all three professional groups was 4.14. The nurses’ 
total mean score was 3.87 and was the lowest, physicians ranked it 4.28 and pharmacists 
4.57 (Fig. 1, circles). The differences between professional groups were statistically signifi-
cant (Welch tests of equality of means: p < 0.001). A statistically significant difference was 
found between the mean scores of pharmacists and nurses (Games-Howell test: p < 0.001), 
but not between the mean scores of physicians and nurses, nor between pharmacists and 
physicians (Fig. 1). Mean scores of agreement with each statement about the role of a clini-
cal pharmacist in the hospital system for pharmacists, physicians and nurses are presented 
in Table I. Among seventeen statements about the clinical pharmacists’ role in the hospital 
system there were thirteen statements with the mean score > 4 for all participants. Eleven 
statements in this group reached the mean score > 4 for pharmacists and physicians.
Pharmacists ranked their agreement higher (mean score ranged from 4.23 to 5) than 
physicians (mean score ranged from 3.69 to 4.80) for fourteen statements and higher than 
nurses (mean score from 3.63 to 4.55) for fifteen statements. For two statements, a statisti-
cally significant difference was found only between pharmacists and nurses.
Statistically significant differences between the mean scores of physicians and nurses 
were found only for the statement, regarding provision of information about medicines 
during different kinds of internal educational courses. All of the 13 pharmacists totally 
agreed with five statements, namely statements number 1, 3, 4, 6 and 16 (Table I).
Pharmacists’ participation in creating pharmacotherapeutic guidelines, its designing 
guidelines and recommendations for improvement of drug administration procedures, 
and providing all kinds of drug information by the pharmacist were statements with the 
highest mean scores in the survey. These are the most valuable activities of clinical phar-
macists reported also by other authors (2, 3).
Hospital pharmacists are usually passive in providing all kinds of information about 
medicines to other health care professionals, i.e., they do that only when asked. In contrast, 
clinical pharmacists do that more systematically and in a proactive way during organized 
meetings in the wards. Despite the statistically significant difference between pharmacists 
and physicians concerning these statements, there is considerably high scores in the physi-
cians’ group too, which indicates their high expectations for a systematic approach to pro-
viding information about medicines by clinical pharmacist. Also Mysak (16) and Chevalier 
and Neville (3) found that ear-marking of an assigned clinical pharmacist for a particular 
ward and a systematic approach in providing clinical pharmacy activities resulted in high-
er level of satisfaction physicians’ and nurses’. For that reason, the high mean score for 
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these statements in the physicians’ group is expected. When comparing the scores for sim-
ilar statements concerning the pharmacists provision of information to the nurses (state-
ments number 2, 5 and 7), the mean scores were much lower for all three professional 
groups. It is interesting that physicians ranked the statements about clinical pharmacists’ 
providing information about medicines to the nurses (statements number 2, 5 and 7) the 
lowest. On the other side, in the nurses’ group, the mean scores for some statements con-
cerning providing information about accessibility and interchangeability of drugs to the 
nurses (statements number 2 and 5) are higher for nurses than for physicians. Based on 
this, we can conclude that it is important for a clinical pharmacist to provide information 
about medicines to physicians and to nurses, providing both professional groups believe 
clinical pharmacists should provide information to their profession with the provision of 
clinical pharmacy services.
For two statements (14 and 15), the mean score of agreement of pharmacists was lower 
than the mean score of agreement of physicians and nurses. Although the differences for 
statement number 14 are not statistically significant, it is important to note that they both 
relate to the pharmacist’s role in dealing with medical devices. In the UMC Ljubljana, medi-
cal devices are provided directly by the purchasing department rather than by the hospital 
pharmacy. This is the reason why pharmacists did not recognize their role in dealing with 
medical devices and they ranked respective statements low. Nurses also ranked these two 
statements considerably low, 3.64 and 3.26, respectively, but physicians’ mean scores were 
4.20 and 3.98, which shows higher expectations of physicians concerning this topic. As far 
as we know, in other hospitals, medical devices are provided in the same way as medi-
cines, i.e., by the hospital pharmacy. There were two statements that directly addressed 
clinical pharmacists’ role in cost containment (statements number 11 and 15). It is interest-
ing that for these two statements the mean scores of agreement were among the lowest for 
all three professional groups. Despite many reports about a positive economic impact of 
clinical pharmacists’ activities in the literature (18–27), physicians and nurses found those 
clinical pharmacists’ activities less important. Budgeting and cost containment in the hos-
pital is the responsibility of managers rather than pharmacists. Taking into account the 
previously mentioned findings, the managing personnel need quality information provid-
ed by clinical pharmacists so that they can make appropriate decisions concerning costs. 
Clinical pharmacists exert their role concerning cost containment through their clinical ac-
tivities including providing of quality information. This is concordant with the conclusion 
of Touchette et al. (7) that clinical pharmacy services are generally considered cost effective 
and provide a good benefit-cost ratio.
The role of the clinical pharmacist with respect to the patient
The total mean score of agreement with the statements about the role of a clinical phar-
macist with respect to the patient was 3.65 for all three professional groups. Pharmacists 
ranked their mean score 4.23, physicians scored the role of the pharmacist with respect to 
the patient 3.73 and nurses 3.38 (Fig. 1). The differences between professional groups were 
statistically significant (Welch tests of equality of means: p < 0.001). A statistically signifi-
cant difference was found between the mean scores of pharmacists and physicians (Games-
Howell test: p = 0.0041) and between the mean scores of pharmacists and nurses (Games-
Howell test: p < 0.001), but not between the mean scores of physicians and nurses (Fig. 1).
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Table II gives the mean scores of agreement with the statements about the role of 
clinical pharmacists with respect to the patient for each professional group, namely, phar-
macists, physicians, and nurses. Among nineteen statements about the role of the clinical 
pharmacist with respect to the patient, eleven statements showed a statistically significant 
differences of the mean score of agreement between the three professional groups (Table 
II). For four statements, the mean scores of agreement of pharmacists were also statistically 
significantly different from the mean scores of agreement of physicians and nurses. For 
three statements, the difference was statistically significant only between the mean scores 
of agreement of pharmacists and nurses, but not between the mean scores of agreement of 
pharmacists and physicians. There were also five statements with statistically significant 
difference between the mean scores of agreement of physicians and nurses.
Among the statements about the role of the clinical pharmacist with respect to the 
patient the statement number 36: »The clinical pharmacist can (has the power to) inter-
change the prescribed medicine with its pharmaceutical alternative without proven 
bioequivalence, but has to inform the physician about the interchange as soon as possible«, 
has obtained the lowest mean score of agreement of all, for all professional groups, al-
though this activity of the pharmacist has achieved very positive outcomes somewhere else 
(2, 27). Actually, therapeutic interchange is a frequent activity of US-based clinical pharma-
cists and its frequency is increasing in some other countries, as well.
Physicians showed clear disagreement (mean score 2.00) also with the statement 
number 35: »The clinical pharmacist can (has the power to) interchange the prescribed 
medicine with its pharmaceutical equivalent without proven bioequivalence, but has to 
inform the physician about the interchange as soon as possible« and with the similar state-
ment about interchanging of essentially similar medicines (statement number 34, mean 
score 2.50). Also, pharmacists were not in favour of performing the activities described in 
statements 35 and 36 (mean scores 3.15 and 2.62). Actually, all three statements concerning 
the power of the pharmacist to interchange the prescribed drugs with other suitable items 
without prior confirmation of the physician (statements 34, 35 and 36) have gained very 
low mean scores of agreement of physicians (mean scores 2.5, 2.00 and 1.93, respectively) 
and nurses (mean scores 2.55, 2.40 and 2.23). In contrast, the mean score of agreement of 
pharmacists with the statement number 34: »The clinical pharmacist can (has the power to) 
interchange essentially similar medications without consultation with the physician, when 
this is necessary for cost- or accessibility-related reasons concerning the prescribed medi-
cine« was considerably high (4.23), whereas the mean scores of agreement of pharmacists 
with the statements about independently interchanging medications without evidence of 
being bioequivalent (statements 35 and 36) were lower for interchanging of pharmaceutical 
equivalents (3.15) and for interchanging of pharmaceutical alternatives (2.61). Research of 
Kjeldsen et al. (2) showed very similar results. One possible explanation for disagreement 
of physicians with all three statements about independent interchanging of medicines by 
clinical pharmacists is that they overlooked the differences between the kinds of drugs to 
be interchanged. Actually, our hospital pharmacy usually supplies only one of the essen-
tially similar medicines and the interchange of the ordered medication is performed in the 
pharmacy. In the ward, prescribed drugs are interchanged with other bioequivalent drugs 
by the nurses on the basis of information from the pharmacy. For the planning of future 
activities of clinical pharmacists in the hospital, it is important to be aware of the physi-
cians’ strong negative attitude towards pharmacists’ competence for independent inter-
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change of prescribed medicines. According to the literature, there are some other activities 
of clinical pharmacists that have demonstrated a very positive impact on the outcomes of 
medication therapy, among them participation of the pharmacist in medical rounds, taking 
medication history, medication reconciliation and giving advice to the patient at discharge, 
etc. (2, 3, 27). Notwithstanding, our survey has established significantly lower mean scores 
of agreement of physicians and nurses with the respective statements. Physicians expressed 
a surprisingly low support (mean score 3.32) to participation of clinical pharmacists in 
medical rounds, while nurses were even against it (mean score 2.89). On the other hand, 
physicians expressed a high level of agreement with some other statements concerning 
clinical pharmacists’ participation in activities aimed at achieving good and safe pharma-
cotherapy, as seen for statements number 20 (mean score 4.15), 21 (mean score 4.75), 27 
(mean score 4.42), 28 (mean score 4.32) and 33 (mean score 4.10). They also support clinical 
pharmacists’ access to patients’ medical records, described in statement 32 (mean score 
4.11). It is interesting that nurses expressed their negative opinion concerning this state-
ment (mean score 2.83). Also, the agreement of nurses with some other statements about 
clinical pharmacists’ cooperation with physicians is considerably lower compared to phy-
sicians. These are statements number 20 (mean score 3.00), 25 (mean score 3.85), 27 (mean 
score 3.45), 32 (mean score 2.83) and 33 (mean score 3.12). Nurses showed a rather reserved 
attitude even to typically pharmaceutical activities like preparation (statements 22 and 23) 
of medications, compatibility issues (statements 24, 25 and 26), dispensing of medications 
at discharge (statement 30) and pharmacovigilance (statement 27), when perform in the 
wards. This may be due to the nurse fear that clinical pharmacists would be a kind of in-
spection over their professional field. Among the statements about the role of clinical phar-
macists with respect to the patient, nurses ranked > 4 only one statement (number 21, mean 
score 4.31).
Limitations of the research
Of more than 1100 physicians and more than 3500 nurses in the UMC Ljubljana, only 
40 head physicians and 42 head nurses were included in the survey. Sampling was deliber-
ately directed because we wanted to research the perception of and attitude towards the 
clinical pharmacy service of the middle management health care professionals who lead 
and direct activities in the wards. In spite of the small sample, we expected to get better 
information about the possibilities of introducting the clinical pharmacy service into the 
hospital in this way. The survey was anonymous and we can assume its validity was not 
diminished by possible social desirability bias.
In addition, the number of participating pharmacists is considerably low. Neverthe-
less, all thirteen pharmacists, who were interested in performing clinical pharmacy serv-
ices, answered the questionnaire, so we determined a 100 % response rate for pharmacists. 
Moreover, for statements 27, 28, 29, 34, 35, and 36, more than 10 %, of the data was missing 
(number of responses was 84 or lower), which occurred mainly in the nurses’ group. The 
terms in these statements are specifically connected with the pharmacy profession and may 
not be adequately understood by other health care professionals, especially nurses. This is 
the possible reason for the considerably high rate of missing data. Additionally, all three 
statements about the power of the pharmacist to independently interchange the prescribed 
medication (statements 34–36) were, despite considerable differences in professional con-
tent (bioequivalent vs. non-bioequivalent medications), ranked very similarly by physi-
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cians and nurses. The possible reason could be the mind-set bias because of small differ-
ences in the text of statements and the position bias because of the sequential order of these 
three statements. We suggest to other authors who would like to use our questionnaire to 
merge these three statements.
CONCLUSIONS
In this research, we identified the most important clinical pharmacy activities from the 
users’, i.e., physicians’ and nurses’ point of view, and from the pharmacists’ on the other 
side. There is a substantial difference in the opinion about the importance of a particular 
activity between pharmacists as providers and physicians and nurses as users. In the ma-
jority of cases, pharmacists ranked their agreement with the statements higher (4.57 in the 
hospital system group and 4.23 in the patient set of statements) than physicians (4.28 and 
3.73, respectively) and nurses (3.78 and 3.38, respectively). Nurses expect clinical pharma-
cists to provide information about medicines to the nursing staff, including advice concern-
ing storage of medication. Physicians’ expectations are much more clinically oriented. 
They expect clinical pharmacists to analyse and consult patients’ pharmacotherapies, de-
tect drug related problems and suggest changes or optimization of the therapy. However, 
physicians’ perception of the role of the clinical pharmacist is more traditional and they are 
not in favour of passing the right to perform independent interventions of pharmacothera-
py to clinical pharmacists. Nevertheless, they all agree that pharmacists should have access 
to medical records.
Performing research and analysis of the future »market stakeholders’« attitude to-
wards the newly planned service is a more managerial and proactive approach, which can 
avert providers from performing unnecessary or even unwanted activities. We conducted 
the survey using the same set of questions for all three professional groups. This allowed 
us to compare the answers concerning a particular clinical pharmacy activity among differ-
ent professions. This can be a useful starting point for other researchers in this field.
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